Skye Bioscience, Inc. Common Stock share price logo

Skye Bioscience, Inc. Common Stock Share Price

NASDAQ: SKYE

Small Cap

$0.83

+0.03

(+3.54%)

as on

Skye Bioscience, Inc. Common Stock Stock Performance

as on February 7, 2026 at 7:59 am IST

  • Day's Low

    Day's High

    $0.80
    $0.84
    downward going graph

    3.61%

    Downside

    1.20%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.68
    $5.75
    downward going graph

    17.54%

    Downside

    592.77%

    Upside

    downward going graph

Skye Bioscience, Inc. Common Stock share price movements today

Previous Close
$0.80
Open
$0.81
Volume
581.6K
Day's Low - High
$0.80 - $0.84
52 Week Low - High
$0.68 - $5.75

Skye Bioscience, Inc. Common Stock Historical Returns

1 Month Return
-26.19 %
3 Month Return
-46.45 %
1 Year Return
-73.91 %
3 Year Return
-92.59 %
5 Year Return
0 %

Skye Bioscience, Inc. Common Stock Stock Fundamentals & Key Indicators

Check Skye Bioscience, Inc. Common Stock market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$32.7M

EPS (TTM)

-1.3429

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-94.31%

Skye Bioscience, Inc. Common Stock vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Skye Bioscience, Inc. Common Stock with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Skye Bioscience, Inc. Common Stock image
Skye Bioscience, Inc. Common Stock
NA$32.7MNANA0.00%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$122.3B122.02%33.5631.35%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$47.7B98.75%1246.031.36%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$37.4BNA662.331.38%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$80.8B57.42%18.2832.13%

Stock Returns calculator for Skye Bioscience, Inc. Common Stock Stock including INR - Dollar returns

The Skye Bioscience, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Skye Bioscience, Inc. Common Stock investment value today

Current value as on today

₹29,742

Returns

₹70,258

(-70.26%)

Returns from Skye Bioscience, Inc. Common Stock Stock

₹73,567 (-73.57%)

Dollar Returns*

₹3,309 (+3.31%)

Skye Bioscience, Inc. Common Stock Stock’s Investor Sentiment and Interest

Search interest for Skye Bioscience, Inc. Common Stock Stock has decreased by -17% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-17% versus previous 30 day period

Skye Bioscience, Inc. Common Stock Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Total Revenue
-
-
0
-
-
-
-
-
-
-
Gross Profit
0
0
0
0
0
0
0
0
0
-
Operating Income
-2
-24
-4
-6
-8
-4
-10
-11
-18
-13
EBITDA
-2
-24
-4
-4
-7
-3
-9
-10
-17
-12
Interest Expense
0
0
0
0
0
0
0
0
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-3
-24
-4
-5
-7
-3
-9
-11
-17
-12
Income Tax Expense
0
0
0
0
0
-
-
0
0
-
Net Income
-3
-24
-4
-5
-7
-3
-9
-11
-17
-12
Net Profit Margin
0.00%
0.00%
-2705.16%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Skye Bioscience, Inc. Common Stock Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
0
0
0
0
0
Operating Income
-3
-4
-6
-6
-7
-18
-34
-30
EBITDA
-3
-4
2
-5
-7
-18
-36
-25
Interest Expense
0
0
1
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
Income Before Tax
-3
-19
1
-6
-8
-19
-37
-26
Income Tax Expense
0
0
0
0
0
0
0
0
Net Income
-3
-19
1
-6
-8
-19
-37
-26
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Skye Bioscience, Inc. Common Stock Quarterly Cash Flow

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Net Income
-24
-4
-5
-7
-3
-9
-11
-17
-12
Operating Cash Flow
-4
-3
-4
-7
-5
-8
-9,185
-10
-13
Investing Cash Flow
1
0
1
0
-1
0
-12,808
-11
7
Financing Cash Flow
16
0
85
-2
-
0
-
0
-
Change in Cash
13
-3
82
-9
-6
-8
-21,994
-22
-5

Skye Bioscience, Inc. Common Stock Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-3
-3
-19
1
-6
-8
-19
-37
-26
Operating Cash Flow
-3
-3
-3
-6
-6
-6
-12
-13
-25
Investing Cash Flow
0
0
0
0
0
0
5
6
0
Financing Cash Flow
0
3
5
6
6
13
0
16
83
Change in Cash
-3
0
1
0
0
6
-7
9
58

Insights on Skye Bioscience, Inc. Common Stock

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Beone Medicines Ltd has given 58.4% return, outperforming this stock by 132.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 42.1% return, outperforming this stock by 134.7%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, SKYE stock has moved down by -18.9%

About Skye Bioscience, Inc. Common Stock

Skye Bioscience, Inc. is a clinical-stage biotechnology company. The Company is focused on development of next-generation molecules that modulate G-protein coupled receptors to treat obesity, overweight, and related conditions. The Company’s lead candidate, nimacimab, is a peripherally restricted negative allosteric modulating antibody targeting cannabinoid receptor 1 (CB1). The Company is also focused on its Phase IIa clinical trial, CBeyond, for nimacimab. The CBeyond clinical trial includes approximately 136 patients, 16 clinical trial sites and a combination arm with a GLP-1 receptor agonist to assess differences in weight loss, body composition, and other attributes. The CB1 receptor is one of the receptors in the endocannabinoid system (ECS) and plays a significant role both in the central nervous system (CNS) and peripheral tissues. The Company's Phase II study in obesity for nimacimab, is a negative allosteric modulating antibody that peripherally inhibits CB1.
OrganisationSkye Bioscience, Inc. Common Stock
Headquarters11250 El Camino Real, San Diego, CA, United States, 92130
CEOMr. Punit S. Dhillon B.A.
E-voting on sharesClick here to vote

Key Management of Skye Bioscience, Inc. Common Stock

Name

Title

Mr. Punit S. Dhillon B.A.

President, CEO, Secretary & Director

Ms. Kaitlyn Melanie Arsenault CPA

Chief Financial Officer

Mr. Tu Diep M.Sc.

Chief Operating Officer

Dr. Christopher G. Twitty Ph.D.

Chief Scientific Officer

Mr. Brennen Brodersen J.D.

General Counsel

Dr. Puneet S. Arora FACE, M.D., M.S.

Chief Medical Officer

FAQs

What is Skye Bioscience, Inc. Common Stock share price today?

Skye Bioscience, Inc. Common Stock share price today is $0.83 as on at the close of the market. Skye Bioscience, Inc. Common Stock share today touched a day high of $0.84 and a low of $0.8.

What is the 52 week high and 52 week low for Skye Bioscience, Inc. Common Stock share?

Skye Bioscience, Inc. Common Stock share touched a 52 week high of $5.75 on and a 52 week low of $0.68 on . Skye Bioscience, Inc. Common Stock stock price today i.e. is closed at $0.83,which is 85.57% down from its 52 week high and 21.27% up from its 52 week low.

What is Skye Bioscience, Inc. Common Stock's market capitalisation today?

Skye Bioscience, Inc. Common Stock market capitalisation is $0.00T as on .

How to invest in Skye Bioscience, Inc. Common Stock Stock (SKYE) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Skye Bioscience, Inc. Common Stock on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Skye Bioscience, Inc. Common Stock Shares that will get you 1.8072 shares as per Skye Bioscience, Inc. Common Stock share price of $0.83 per share as on February 7, 2026 at 2:29 am IST.

What is the minimum amount required to buy Skye Bioscience, Inc. Common Stock Stock (SKYE) from India?

Indian investors can start investing in Skye Bioscience, Inc. Common Stock (SKYE) shares with as little as ₹90.555 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹905.55 in Skye Bioscience, Inc. Common Stock stock (as per the Rupee-Dollar exchange rate as on ). Based on Skye Bioscience, Inc. Common Stock share’s latest price of $0.83 as on February 7, 2026 at 2:29 am IST, you will get 12.0482 shares of Skye Bioscience, Inc. Common Stock. Learn more about fractional shares .